The Supply of Bio Products Laboratory Branded Pharmaceuticals
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
Published
20 Feb 2025
Description
Leidos Supply Ltd. intends to award a single source framework for the provision of Bio Products Laboratory Branded Pharmaceutical Products for the UK Ministry of Defence. The agreement will be for the duration of 3 years. It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (2)(b)(iii) of Directive 2014/24/EC of the European Parliament (Regulation 32(2)(b) of Public Contracts Regulations 2015). These products are manufactured by Bio Products Laboratory and are only available through a contract direct with Bio Products Laboratory. The estimated 3-year value is £406,897 - £1,017,242 GBP.
Scope
- Reference
- LSL/MED/0141
- Commercial tool
- Standalone contract
- Main category
- goods
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Lowest price | — | price | — |
Submission & procedure
- Procedure
- Negotiated without publication of a contract notice
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded suppliers· 1 supplier
Awarded —
Other contracts from Ministry of Defence, DE&S, LDOC
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Bio Products Laboratory Ltd.· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NP34925a Hepatitis B immunoglobulin intramuscular use (IM) | contract | — | 02 May 2025 |
| NP34925b Tetanus immunoglobulin intramuscular use (IM) | contract | — | 02 May 2025 |
| NP34925c Anti Rabies immunoglobulin intramuscular use (IM) | contract | — | 02 May 2025 |
| NP34925c Anti Rabies immunoglobulin intramuscular use (IM) | contract | — | 14 Apr 2025 |
| NP34925b Tetanus immunoglobulin intramuscular use (IM) | contract | — | 14 Apr 2025 |
| NP34925a Hepatitis B immunoglobulin intramuscular use (IM) | contract | — | 14 Apr 2025 |
| Immunoglobulins (2025) | contract | — | 18 Mar 2025 |
| NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin | contract | — | 20 Jan 2025 |
| NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin | contract | — | 29 Nov 2024 |
| Human Derived Blood Products | contract | — | 28 Aug 2024 |